Five Prime Therapeutics Inc (NASDAQ:FPRX)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - FPRX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - FPRX

  • Market Cap$208.050m
  • SymbolNASDAQ:FPRX
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS33830X1046

Company Profile

Five Prime Therapeutics Inc is a biotechnology company focused on discovering and developing protein therapeutics for diseases. The company's product candidates address patient populations for which therapies are still needed. Its is focused on advancing its internal pipeline and retaining rights for products in targeted specialty markets. It also seeks to establish additional collaborations to supplement its internal development capabilities. These collaborations generate additional funding in order to further validate the company's technology. It has the following product in pipeline: Cabiralizumab, FPA150, Bemarituzumab and Immuno-Oncology.Five Prime Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel protein therapeutics to improve lives of patients with serious diseases.

Latest FPRX news

Currently there for this company. Visit our news hub for other news .